September 16, 2014 1:51 PM ET

Biotechnology

Company Overview of Idenix Pharmaceuticals Inc.

Executive Profile

Julio Sergio Gonzalez Montaner M.D.

AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 5 different industries.

See Board Relationships
----

Background

Dr. Julio Sergio Gonzalez Montaner, M.D., serves as the Professor of Medicine and Director of Clinical Activities at the University of British Columbia, British Columbia Center for Excellence in HIV/AIDS, Vancouver, B.C., Canada. Dr. Montaner serves as National Co-Director of Canadian HIV Trials Network, and serves as founding chair on AIDS at St. Paul's Hospital. In 1988, Dr. Montaner joined St. Paul's Hospital as Director of the AIDS Research Program and the Infectious ...

Corporate Headquarters

320 Bent Street
Cambridge, Massachusetts 02141

United States

Phone: 617-995-9800
Fax: 617-995-9801

Board Members Memberships

Director

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Idenix Pharmaceuticals Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.